Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current Limitations and Candidate Potential of 5-HT7 Receptor Antagonism in Psychiatric Pharmacotherapy
Ruri Okubo, Toshiki Hasegawa, Kouji Fukuyama, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

5-HT Receptors and the Development of New Antidepressants
Grzegorz Ślifirski, Marek Król, Jadwiga Turło
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 9015-9015
Open Access | Times Cited: 72
Formulation, Characterization, and Evaluation of β-Cyclodextrin Functionalized Hypericin Loaded Nanocarriers
Muhammad Ahsan Waqar, Muhammad Zaman, Huma Hameed, et al.
ACS Omega (2023) Vol. 8, Iss. 41, pp. 38191-38203
Open Access | Times Cited: 25
Pharmacological targeting of cognitive impairment in depression: recent developments and challenges in human clinical research
Michael Colwell, Hosana Tagomori, Sarah Chapman, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 31
Functional Dimerization of Serotonin Receptors: Role in Health and Depressive Disorders
Еlena V. Mitroshina, Ekaterina A. Marasanova, Maria V. Vedunova
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16416-16416
Open Access | Times Cited: 18
Recent developments in intranasal drug delivery of nanomedicines for the treatment of neuropsychiatric disorders
Anglina Kisku, Ambresh Nishad, Saurabh Agrawal, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 8
Central nervous system effects of 5-HT7 receptors: a potential target for neurodegenerative diseases
Alejandro Quintero-Villegas, Sergio Iván Valdés‐Ferrer
Molecular Medicine (2022) Vol. 28, Iss. 1
Open Access | Times Cited: 27
Therapeutic Potential and Limitation of Serotonin Type 7 Receptor Modulation
Kouji Fukuyama, Eishi Motomura, Motohiro Okada
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2070-2070
Open Access | Times Cited: 15
Dysfunction of the NMDA Receptor in the Pathophysiology of Schizophrenia and/or the Pathomechanisms of Treatment-Resistant Schizophrenia
Ruri Okubo, Motohiro Okada, Eishi Motomura
Biomolecules (2024) Vol. 14, Iss. 9, pp. 1128-1128
Open Access | Times Cited: 4
Efficacy of lurasidone in adults with bipolar depression: A systematic review and meta-analysis of its impact on depressive symptoms and disability
Rosario Aronica, Claudia Pagani, Valeria Favalli, et al.
Journal of Affective Disorders (2025)
Closed Access
Effects of Atypical Antipsychotics, Clozapine, Quetiapine and Brexpiprazole on Astroglial Transmission Associated with Connexin43
Kouji Fukuyama, Motohiro Okada
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5623-5623
Open Access | Times Cited: 20
Vortioxetine as a new frontier in the treatment of chronic neuropathic pain: a review and update
Daniela Adamo, Elena Calabria, Noemi Coppola, et al.
Therapeutic Advances in Psychopharmacology (2021) Vol. 11
Open Access | Times Cited: 20
Cognitive Effects of Lurasidone and Cariprazine: A Mini Systematic Review
Miriam Olivola, Nicola Bassetti, Serena Parente, et al.
Current Neuropharmacology (2023) Vol. 21, Iss. 12, pp. 2431-2446
Closed Access | Times Cited: 8
A Randomized, Double-blind, Placebo-controlled Proof-of-Concept Trial to Evaluate the Efficacy and Safety of Non-racemic Amisulpride (SEP-4199) for the Treatment of Bipolar I Depression
Antony Loebel, Kenneth S. Koblan, Joyce Tsai, et al.
Journal of Affective Disorders (2021) Vol. 296, pp. 549-558
Open Access | Times Cited: 18
Impact of 5-HT7 receptor inverse agonism of lurasidone on monoaminergic tripartite synaptic transmission and pathophysiology of lower risk of weight gain
Kouji Fukuyama, Eishi Motomura, Takashi Shiroyama, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 148, pp. 112750-112750
Open Access | Times Cited: 12
Dose-Dependent Biphasic Action of Quetiapine on AMPK Signalling via 5-HT7 Receptor: Exploring Pathophysiology of Clinical and Adverse Effects of Quetiapine
Motohiro Okada, Kouji Fukuyama, Eishi Motomura
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9103-9103
Open Access | Times Cited: 12
Design, synthesis, and biological evaluation of aralkyl piperazine and piperidine derivatives targeting SSRI/5-HT1A/5-HT7
Jianwei Wu, Zixue Zhang, Qingwei Zhang, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 104, pp. 117698-117698
Closed Access | Times Cited: 2
Chronic Administrations of Guanfacine on Mesocortical Catecholaminergic and Thalamocortical Glutamatergic Transmissions
Kouji Fukuyama, Tomosuke Nakano, Takashi Shiroyama, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 4122-4122
Open Access | Times Cited: 15
Distinct Effects of Escitalopram and Vortioxetine on Astroglial L-Glutamate Release Associated with Connexin43
Takashi Shiroyama, Kouji Fukuyama, Motohiro Okada
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 10013-10013
Open Access | Times Cited: 13
Brexpiprazole Reduces 5-HT7 Receptor Function on Astroglial Transmission Systems
Kouji Fukuyama, Eishi Motomura, Motohiro Okada
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6571-6571
Open Access | Times Cited: 9
A Novel Gliotransmitter, L-β-Aminoisobutyric Acid, Contributes to Pathophysiology of Clinical Efficacies and Adverse Reactions of Clozapine
Kouji Fukuyama, Eishi Motomura, Motohiro Okada
Biomolecules (2023) Vol. 13, Iss. 9, pp. 1288-1288
Open Access | Times Cited: 5
Design and synthesis of new potent 5-HT7 receptor ligands as a candidate for the treatment of central nervous system diseases
Damian Kułaga, Anna K. Drabczyk, Grzegorz Satała, et al.
European Journal of Medicinal Chemistry (2021) Vol. 227, pp. 113931-113931
Closed Access | Times Cited: 12
A Candidate Gliotransmitter, L-β-Aminoisobutyrate, Contributes to Weight Gain and Metabolic Complication Induced by Atypical Antipsychotics
Kouji Fukuyama, Eishi Motomura, Motohiro Okada
Nutrients (2023) Vol. 15, Iss. 7, pp. 1621-1621
Open Access | Times Cited: 4
Enhanced L-β-Aminoisobutyric Acid Is Involved in the Pathophysiology of Effectiveness for Treatment-Resistant Schizophrenia and Adverse Reactions of Clozapine
Kouji Fukuyama, Eishi Motomura, Motohiro Okada
Biomolecules (2023) Vol. 13, Iss. 5, pp. 862-862
Open Access | Times Cited: 4
Modulation of neuronal morphology by antipsychotic drug: Involvement of serotonin receptor 7
Luisa Speranza, Marta Molinari, Floriana Volpicelli, et al.
Brain Research (2024) Vol. 1830, pp. 148815-148815
Open Access | Times Cited: 1
Vortioxetine treatment for neuropathic pain in major depressive disorder: a three-month prospective study
Sinan Eliaçık, Ayşe Erdoğan Kaya
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top